Sumatriptan
Sumatriptan improved global       quality-of-life scores compared with patients' usual therapy in a randomised       crossover trial and appeared to do the same when the drugs were administered in       nonblinded, sequential phases in trials which used general and migraine-specific        quality-of-life instruments.
 @SUBJECT$  improved global       quality-of-life scores  @PREDICAT$  with patients' usual  @OBJECT$  in a randomised       crossover trial and appeared to do the same when the drugs were administered in       nonblinded, sequential phases in trials which used general and migraine-specific        quality-of-life instruments.